Buy-side AML/KYC compliance in life settlements operates in a nuanced regulatory position. Life insurance carriers issuing the underlying policies are covered "financial institutions" under BSA with mandatory AML program requirements. Banks and broker-dealers facilitating investor capital flows operate under their own BSA obligations. But life settlement buy-side entities themselves — SPVs, investment vehicles, direct acquisition structures — are generally not designated financial institutions under BSA. This creates an operational reality where the buy-side entity sits at the intersection of multiple regulated ecosystems without being directly subject to BSA program requirements. Institutional-grade practice voluntarily adopts the FinCEN 5-pillar framework to support counterparty confidence, meet investor onboarding standards, and prepare for potential future designation. After more than two decades coordinating buy-side AML/KYC frameworks across life settlement acquisitions, the framework below organizes the operational compliance discipline that distinguishes institutional practice.

BSA applicability analysis for buy-side entities

Understanding BSA applicability to buy-side life settlement entities requires distinguishing among three categories: covered insurance companies with mandatory AML programs, covered banks and broker-dealers with mandatory AML programs, and buy-side entities that typically fall outside direct BSA designation.

Insurance companies as covered financial institutions. FinCEN regulations at 31 CFR 1025.210 and 1025.320 impose AML compliance program requirements and Suspicious Activity Report (SAR) obligations on insurance companies. A covered product for AML program purposes includes: (1) a permanent life insurance policy other than a group life insurance policy; (2) any annuity contract other than a group annuity contract; (3) any other insurance product with features of cash value or investment. Life insurance carriers issuing the underlying policies in life settlement transactions are covered financial institutions subject to full BSA obligations.

Brokers and agents excluded from independent obligations. Per FFIEC BSA/AML Manual, the FinCEN insurance regulations apply only to insurance companies — there are no independent obligations for brokers and agents. However, the insurance company is responsible for the conduct and effectiveness of its AML compliance program, which includes agent and broker activities. This structural framework means that life settlement providers and brokers, while operating within the insurance ecosystem, are not themselves directly designated as covered financial institutions requiring independent AML programs.

Life settlement buy-side entities. The buy-side entity (SPV, investment vehicle, direct acquisition structure) purchasing life settlement policies is generally not a covered "financial institution" under BSA. FinCEN has not extended AML program requirements specifically to life settlement acquirers as a category. This creates the operational reality where the buy-side entity acquires policies from covered insurance carriers (via non-covered providers/brokers) using investor capital that flowed through covered bank/broker-dealer relationships — sitting at the intersection of regulated ecosystems without being directly regulated.

Voluntary compliance framework. Institutional-grade buy-side operators voluntarily implement the FinCEN 5-pillar framework despite the absence of direct BSA designation. Rationale includes: (1) counterparty confidence — insurance carriers and providers prefer transacting with counterparties operating under recognized AML frameworks; (2) investor onboarding standards — investors funding acquisitions expect institutional-grade AML/KYC practices at every ecosystem participant; (3) future regulatory readiness — the FinCEN April 2026 proposed rule modernizes AML/CFT program requirements, and life settlement designation may follow future rulemaking; (4) OFAC sanctions compliance which applies to all U.S. persons regardless of BSA designation.

5-pillar AML/KYC framework

The FinCEN 5-pillar AML/CFT program framework, formalized under the 2016 CDD Final Rule, provides the structural foundation for institutional-grade compliance. The framework below organizes the five pillars with buy-side life settlement operational application.

The 5-pillar framework operates as an integrated compliance system rather than as five independent activities. Institutional-grade buy-side implementation typically includes: BSA/AML officer with clear reporting line to senior management; documented written policies covering all AML activities; annual training program with role-specific modules; annual independent testing conducted by qualified internal audit or external firm; and risk-based CDD workflow integrated into investor onboarding and ongoing monitoring. The 2016 CDD Final Rule (formally effective May 11, 2018) added beneficial ownership identification requirements now integrated into standard institutional practice.

4-tier source of funds verification workflow

Source of funds (SOF) verification is a central operational element of buy-side AML/KYC discipline. The 4-tier workflow below organizes verification activities from investor onboarding through ongoing monitoring, supporting both counterparty confidence and future regulatory readiness.

The 4-tier workflow operates as sequential verification tiers rather than parallel activities. Tier 01 completes at investor onboarding before first allocation; Tier 02 executes with each capital commitment; Tier 03 runs continuously with defined refresh cadence; Tier 04 operates throughout the multi-year holding period. Documentation retention aligns with BSA general framework — five years minimum for buy-side voluntary practice, with some institutional operators extending to seven years to align with tax reporting standards.

OFAC sanctions screening

OFAC (Office of Foreign Assets Control) sanctions screening applies to all U.S. persons regardless of BSA designation. This makes OFAC compliance a mandatory element of buy-side operations even without direct BSA program obligations.

• SDN List screening. All investors and their beneficial owners screened against the OFAC Specially Designated Nationals and Blocked Persons List at onboarding and on ongoing basis. Modern screening typically uses fuzzy-matching algorithms accommodating name variations, transliterations, and alternative spellings.
• SSI List screening. Sectoral Sanctions Identification List screening applies for sector-specific sanctions programs. Life settlement transactions typically do not directly involve SSI-covered sectors, but investor entity screening includes SSI verification for completeness.
• Country-based sanctions. Comprehensive sanctions programs affect Cuba, Iran, North Korea, Syria, Russia (partial), and other jurisdictions per OFAC designations. Investor entity domicile and beneficial owner nationality screened against country-based programs.
• Blocked property reporting. If OFAC screening identifies a match, the buy-side entity must comply with blocked property requirements — freezing assets and reporting to OFAC. Practical response typically includes: immediate transaction hold, legal counsel notification, OFAC reporting via Compliance Reporting Portal, and coordination with impacted counterparties.
• Ongoing screening cadence. Institutional-grade practice includes quarterly re-screening of the full investor base against updated OFAC lists. Some operators use continuous automated screening with real-time list updates rather than periodic batch screening.
• PEP (Politically Exposed Person) screening. Not directly required by OFAC framework, but institutional best practice includes PEP screening for enhanced due diligence trigger identification. FDIC PEP guidance clarifies that banks are not required to have unique additional due diligence steps for PEPs — but risk-based CDD may warrant enhanced review.

Corporate Transparency Act BOI integration

The Corporate Transparency Act (CTA), effective January 1, 2024, requires most U.S. corporations, LLCs, and similar entities to report beneficial ownership information (BOI) to FinCEN. CTA BOI reporting affects life settlement buy-side operations across two dimensions.

• Buy-side entity BOI reporting. SPVs, investment vehicles, and direct acquisition structures organized under U.S. law are typically reporting companies under CTA and must file BOI reports with FinCEN. Report identifies beneficial owners exercising substantial control or owning 25%+ equity interest.
• Entity investor BOI verification. Investors participating through entities (LLCs, partnerships, corporations, trusts) provide BOI information that supports buy-side CDD. Institutional-grade investor onboarding aligns entity investor BOI data with independent verification against FinCEN BOI database or equivalent documentation.
• Report update requirements. BOI reports must be updated within 30 days of any material change in beneficial ownership information. Buy-side entities and entity investors both face ongoing update obligations affecting their AML/KYC workflows.
• Exemption analysis. Certain entity categories are exempt from CTA BOI reporting including large operating companies with 20+ employees and $5M+ revenue, publicly-traded companies, and certain regulated entities. Buy-side and investor entities must analyze exemption status; most life settlement SPVs and investor entities do not qualify for exemptions.
• Foreign entity considerations. Foreign entities registered to do business in the U.S. are also reporting companies under CTA. Foreign investor entities may face BOI reporting obligations affecting their participation in U.S. life settlement transactions.
• Enforcement framework. CTA violations carry civil penalties up to $500 per day and criminal penalties up to $10,000 and 2 years imprisonment for willful violations. Buy-side compliance frameworks incorporate CTA BOI reporting into overall AML/KYC discipline.

For accredited investors evaluating life settlement investments through institutional-grade buy-side operators, verification that CTA BOI reporting and OFAC sanctions screening are systematically incorporated into the buy-side compliance framework provides confidence in operational discipline supporting the multi-year holding period.

Frequently asked questions

Disclaimer — This content is for educational and informational purposes only and does not constitute legal, regulatory, financial, tax, compliance, or investment advice. The BSA applicability analysis reflects general regulatory framework as revised through publication date; specific application to any particular buy-side entity requires qualified BSA/AML counsel review. FinCEN insurance company AML program requirements at 31 CFR 1025.210 and 1025.320 apply to insurance carriers (issuers of permanent life insurance other than group, annuity contracts other than group, and any product with cash value or investment features); FFIEC BSA/AML Manual confirms these regulations apply only to insurance companies with no independent obligations for brokers and agents. The characterization of life settlement buy-side entities (SPVs, investment vehicles, direct acquisition structures) as typically outside direct BSA designation reflects general regulatory framework; specific structures may face different analysis depending on organizational form and operational activities. The FinCEN 5-pillar framework discussion reflects 31 CFR 1010.230 general framework and 2016 CDD Final Rule (effective May 11, 2018); specific implementation requirements vary based on covered financial institution category. The FinCEN April 7, 2026 proposed rule reference reflects publicly documented rulemaking; the proposed rule was not yet finalized as of publication date and specific requirements may change through final rulemaking. The 4-tier source of funds verification workflow (Investor Onboarding CDD, Capital Origin Verification, OFAC + CTA BOI Screening, Ongoing Monitoring) reflects institutional voluntary compliance framework and HYV operational practice; other buy-side operators may apply different workflow structures. OFAC sanctions screening framework references reflect general regulatory practice; specific screening requirements vary by transaction type and counterparty characteristics. Corporate Transparency Act BOI reporting discussion reflects CTA effective January 1, 2024; specific reporting obligations and exemption analysis require qualified corporate counsel review under CTA framework and any subsequent implementing rulemaking. Life settlement investments are illiquid, long-duration alternative assets and are generally available only to accredited investors as defined under SEC Rule 501 of Regulation D. Investments involve substantial risk, including potential loss of capital. High Yield Vault is a life settlement investment platform that originates, researches, and presents direct-ownership investment opportunities to accredited investors. HYV is not a bank, not a broker-dealer, not a designated BSA financial institution, not a law firm, and not a compliance consulting firm; references throughout to specific regulatory provisions, framework requirements, and operational standards are illustrative of industry-standard practice rather than authoritative interpretation or business relationship. Always consult qualified legal, tax, financial, and compliance advisors familiar with your specific situation before making any allocation, structuring, or compliance decision.